asthma-1920
Application Note

Utilization of AlphaLISA technology to accurately detect asthma biomarkers in human serum

Asthma is a chronic inflammatory disease that affects millions of people around the world. The detection of specific asthma biomarkers in serum can help diagnose and monitor the disease.

AlphaLISA is a bead-based assay technology for the detection of these molecules. This technology was used to quantify biomarker levels in serum samples, specifically Human IL-21, IL-33, and TNFα.

Read this application note to:

  • .discover in detail how AlphaLISA technology can be used to quantify biomarker level in serum samples,
  • ensure proper and accurate detection of biomarkers in serum, dilution linearity and spike-and-recovery experiments to determine the proper diluents and dilution factors required for accurate recovery.

For research use only. Not for use in diagnostic procedures.

To view the full content please answer a few questions

By submitting my personal data, I acknowledge that Revvity Inc. and its affiliates (“Company”) will process my personal data provided above consistent with the Company’s Privacy Policy available here.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Download Resource

Utilization of AlphaLISA technology to accurately detect asthma biomarkers in human serum

Download Application Note